Xeureka Inc. uses the latest computational technology, including cutting-edge AI and simulations, to improve the efficiency and success rates in drug discovery research.
Ultimately, we aim to contribute to the swift, economical delivery of effective medicines to patients suffering from disease.
Company info
Providing computational and AI drug discovery support services for pharmaceutical and biotech companies.
We conduct joint research and development aimed at drug discovery.
| Company Name | Xeureka Inc. |
|---|---|
| Established | November 1, 2021 |
| Representative | Akiko Mutai, President and Representative Director |
| Head Office | Toranomon 30 Mori Bldg. 9F, 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan |
| Shareholders | MITSUI & CO., LTD. |
| Business | Provide Al drug discovery support services Research and development for drug discovery through collaborative research |
| Official account |  |